Literature DB >> 18206295

The involvement of phosphatidylinositol 3-kinase in gonadotropin-releasing hormone-induced gonadotropin alpha- and FSHbeta-subunit genes expression in clonal gonadotroph LbetaT2 cells.

Sandra Mutiara1, Haruhiko Kanasaki, Takashi Harada, Aki Oride, Kohji Miyazaki.   

Abstract

Akt/protein kinase B (Akt/PKB), which is activated by phosphatidylinositol-3 kinase (PI3-kinase), plays an important role in cell survival and cell proliferation. Using the well differentiated, clonal gonadotroph cell line, LbetaT2, we examined (1) whether Akt/PKB was activated by gonadotropin-releasing hormone (GnRH); (2) the contribution of PI3-kinase-Akt/PKB pathway in each of gonadotropin subunit gene expression; (3) crosstalk between extracellular signal-regulated kinase (ERK) and Akt/PKB pathways. Insulin-like growth factor-1 (IGF-1) was used as Akt/PKBs classic activator. Western blot analyses using antibodies specific for the phosphorylated forms of ERK and Akt/PKB demonstrated that both were rapidly phosphorylated following treatment with GnRH and IGF-1. Akt/PKB activation by GnRH and IGF-1 was completely eliminated in the presence of the PI3-kinase inhibitor, LY 294002, but not in the presence of an Akt/PKB inhibitor. Interestingly, the total amount of Akt/PKB protein was dramatically increased in the presence of LY 294002. Phosphorylation of ERK was significantly increased in the presence of LY 294002 alone, and was further increased when GnRH was used in combination with LY 294002. In experiments using a luciferase reporter construct containing the serum response element (SRE), a known target of the ERK pathway, LY 294002 but not the Akt/PKB inhibitor increased SRE-luciferase activity. GnRH-induced SRE-luciferase activity was significantly increased by LY 294002. GnRH stimulation resulted in gonadotropin LHbeta, FSHbeta, and alpha-subunit promoter activation, while IGF-1 failed to stimulate any of them. GnRH-induced gonadotropin promoter activities were not modulated in the presence of an Akt/PKB inhibitor, but treatment with LY 294002 or Wortmannin resulted in a significant increase in alpha- and FSHbeta-subunit promoter activation, both with and without GnRH. LY 294002, but not the Akt/PKB inhibitor, significantly inhibited cell proliferation. These results suggest that GnRH-induced gonadotropin gene expression is not regulated through the Akt/PKB pathway; however, PI3-kinase may be involved in the negative regulation of alpha- and FSHbeta-subunit gene expression as well as cell proliferation.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18206295     DOI: 10.1016/j.mce.2007.12.001

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  5 in total

Review 1.  The regulation of reproductive neuroendocrine function by insulin and insulin-like growth factor-1 (IGF-1).

Authors:  Andrew Wolfe; Sara Divall; Sheng Wu
Journal:  Front Neuroendocrinol       Date:  2014-06-12       Impact factor: 8.606

2.  GnRH pulse frequency differentially regulates steroidogenic factor 1 (SF1), dosage-sensitive sex reversal-AHC critical region on the X chromosome gene 1 (DAX1), and serum response factor (SRF): potential mechanism for GnRH pulse frequency regulation of LH beta transcription in the rat.

Authors:  Laura L Burger; Daniel J Haisenleder; John C Marshall
Journal:  Endocrine       Date:  2011-03-16       Impact factor: 3.633

3.  β-catenin regulates GnRH-induced FSHβ gene expression.

Authors:  Qian Wang; Maria Chikina; Elena Zaslavsky; Hanna Pincas; Stuart C Sealfon
Journal:  Mol Endocrinol       Date:  2012-12-04

4.  Role of PI4K and PI3K-AKT in ERK1/2 activation by GnRH in the pituitary gonadotropes.

Authors:  Tali H Bar-Lev; Dagan Harris; Melanija Tomić; Stanko Stojilkovic; Zeev Blumenfeld; Pamela Brown; Rony Seger; Zvi Naor
Journal:  Mol Cell Endocrinol       Date:  2015-08-01       Impact factor: 4.102

5.  GNRH induces the unfolded protein response in the LbetaT2 pituitary gonadotrope cell line.

Authors:  Minh-Ha T Do; Sharon J Santos; Mark A Lawson
Journal:  Mol Endocrinol       Date:  2008-10-30
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.